INTRODUCTION
An effective immune response is required for successful pathogen clearance. After clearance, the immune response must be terminated to restore immune homeostasis and avoid unwanted tissue damage or chronic inflammation (Viganò et al., 2012) . T helper (Th) cells are central to the adaptive immune system. Depending upon the immunogen or allergen source (e.g., infection, commensal microorganism, or self-antigen), naive Th cells differentiate into several subtypes, including Th1, Th2, Th17, and iTreg, based on their cytokine profile and function .
Upon extracellular pathogen infection (e.g., helminth infection), innate immune cells guide naive Th cells toward a Th2 phenotype. During type 2 immune responses, antigen experienced Th cells proliferate and differentiate toward the Th2 subtype and function through production of various effector cytokines, including interleukin-4 (IL-4), IL-5, IL-9, and IL-13, and at least two suppressor cytokines IL-10 and transforming growth factor (TGF)-b1 (Murphy et al., 2008) . Th2 cells promote B cell class switching to IgE by expressing CD40 ligand (CD40L), IL-4, and IL-13 (Gould and Sutton, 2008) . It is likely that there are undiscovered signaling molecules involved in type 2 immune responses. The active restoration or termination of a type 2 immune response is not well understood, though the importance of active termination has been discussed (Marrack et al., 2010; Viganò et al., 2012) .
Specialized immune cells that act to suppress activation of the immune system and thereby maintain immune homeostasis and tolerance were documented many years ago (Gershon and Kondo, 1971 ) and extensively studied (Germain, 2008) . The existence of suppressor Th2 cells has also been reported both in vivo and in vitro (Altin et al., 2012; Cua et al., 1995; Germain, 2008; Keino et al., 2001) , but the mechanism of suppression is elusive and appears to be context dependent and manifold. Accepted suppression mechanisms by regulatory immune cells are expression of CTLA4 and secretion of IL-10 and TGF-b1 (Schmidt et al., 2012) .
The immunoregulatory role of steroids has been extensively studied (Rhen and Cidlowski, 2005; Sakiani et al., 2013) . It is exploited to treat patients where immunosuppression is required, such as organ transplantation, autoimmune diseases, allergic asthma, and inflammatory dermatitis (Barnes and Adcock, 2003; Gorter et al., 2010; Taylor et al., 2005) . Steroid production is a multienzyme process by which cholesterol is converted to different steroid hormones (Miller and Auchus, 2011) . After synthesis or receptor-mediated endocytosis, cholesterol is transported to the mitochondria through the transduceosome, a multisubunit protein complex composed of voltage-dependent anion channels (VDAC), translocator protein (TSPO), and Star-domain containing protein(s) (Midzak et al., 2011) . Cholesterol synthesis and cellular uptake of cholesterol is necessary to support the de novo steroid biosynthesis.
After mitochondrial transfer, cholesterol is converted to pregnenolone, the first steroid hormone of the pathway, and precursor of all other steroids, by the enzyme Cyp11a1.
Our knowledge of steroid production is largely based on studies of the adrenal cortex, testicular Leydig cells, ovarian granulosa and theca cells, as well as placental syncytiotrophoblast cells (Miller and Auchus, 2011) . Steroid production by other tissues (''local steroid production'') has also been reported, particularly in the nervous system (Baulieu et al., 2001 ). Interestingly, immune-related tissues have also been found to have enzymatic activity for metabolizing steroids (Lechner et al., 2001; Vacchio et al., 1994) . More interestingly, two prominent type 2 immune target tissues, gut and lung, were shown to convert the precursors to glucocorticoids upon type 2 immune activation (Cima et al., 2004; Hostettler et al., 2012) . However, de novo steroid production from immune cells to regulate immune responses is unknown.
By comparing the transcriptomes of different Th subtypes, we discovered an upregulation of an entire steroid synthesis pathway in Th2 cells. We demonstrate de novo pregnenolone production by Th cells in vitro and in vivo and show pregnenolone-dependent inhibition of Th cell proliferation and immunoglobulin class switching in B cells. We speculate that the differentiation of steroidogenic subtype of Th2 cells is an intrinsic phenomenon of type 2 immune responses to restore immune homeostasis and will be relevant to the many molecular processes associated with allergies, asthma, pregnancy, and tumor immunity where Th2 cells are involved.
RESULTS

Transcriptomics Reveals Upregulation of a Steroid Synthesis Pathway in Th2 Cells
Analysis of our RNA sequencing data of murine naive and Th2 cells (NCBI Gene Expression Omnibus accession numbers: GSE28666 [Th2] and GSE31555 [naive, Th1] ) revealed that Th2 lymphocytes express mRNAs encoding all the protein factors involved in the cholesterol synthesis, cholesterol uptake, mitochondrial transfer, and a steroid synthesis pathway (Figure 1 ). This pathway is shut down in naive Th cells but upregulated upon T cell receptor (TCR)-and IL-4-mediated activation and differentiation toward Th2 cells ( Figures 1A and S1A) . We validated the observed upregulation by quantitative PCR (qPCR) for selected genes ( Figure S1B suggests the presence of pathway components up to the production of the steroid pregnenolone. The transcripts of enzymes downstream of pregnenolone, Cyp17a1 and Hsd3b, were undetectable (Figures 1 and S1A ). The gene expression patterns of key transcription factors and cytokines validate the characteristics of Th1 and Th2 cell populations ( Figures  S1C and S1D ). Note that all the genes involved in cholesterol biosynthesis and uptake were also upregulated in Th1 cells, but the steroid production pathway was incomplete in Th1 cells due to the absence of Cyp11a1 upregulation ( Figures  1B and S1A ).
Cyp11a1 Is Differentially Upregulated in Th2 Cells
Cyp11a1 is a key rate-limiting enzyme controlling the entry into the steroid synthesis pathways, by catalyzing the conversion of cholesterol to pregnenolone. The availability of the Cyp11a1 enzyme determines the initial step of de novo steroid production (Miller and Auchus, 2011) . We analyzed and compared the Cyp11a1 mRNA expression level using both RNA sequencing (RNA-seq) ( Figure 1B ) and qPCR (Figure S1B, last panel) in different Th cell subtypes and found it to be differentially upregulated in Th2 cells at the population level.
To check mRNA expression at the single-cell level, naive Th cells from IL-13-eGFP mice were activated under conditions inducing Th2 differentiation. IL-13-eGFP-negative, undivided cells (G0N) and IL-13-eGFP-positive cells that had undergone four cycles of cell division (G4P IL-13 + Th2) were fluorescenceactivated cell sorted (FACS) as single cells ( Figure S2A ). mRNA expression levels in single cells showed an increased Cyp11a1 expression over the course of maturation, with a significantly higher mean Cyp11a1 expression in G4P IL-13 + Th2 cells compared to G0N Th2 cells ( Figure S2B ). Because mRNA expression does not always correlate with protein synthesis, we investigated Cyp11a1 abundance directly at the protein level. We noted differential upregulation of the protein in Th2 cells, compared to naive and Th1 ( Figure 1C ). When we determined Cyp11a1 protein levels in FACS-sorted homogeneous IL-13 + Th2 cells, we found similar upregulation ( Figure S2C ).
Th2 Lymphocytes Produce Pregnenolone In Vitro
Cyp11a1-positive cells are considered as steroidogenic and expected to produce steroids de novo (Miller and Auchus, 2011) . To examine steroid production, Th1 and Th2 culture supernatants were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) for quantitative detection of different steroids, including pregnenolone. We found that Th2 cells produce a significant amount of pregnenolone compared to a media-only control or Th1 cell supernatant ( Figure 2A ). We were unable to detect the presence of other steroids downstream of pregnenolone, such as progesterone or 17-hydroxypregnenolone (data not shown). Quantitative ELISA tests with the Th1 and Th2 cell supernatants validated this Th2-specific pregnenolone production ( Figure 2B ). Steroid production by Th2 cells was sensitive to aminoglutethimide (AG), an inhibitor of Cyp11a1 (Figure 2C ), which suggests that production is actively catalyzed by Cyp11a1.
In vitro pregnenolone production suggests that Th cells may produce pregnenolone during a type 2 immune response in vivo, a hypothesis, which we set out to test using an in vivo helminth infection model.
Th2 Lymphocytes Produce Pregnenolone In Vivo
The nematode Nippostrongylus brasiliensis infection model in mice is used extensively to study the type 2 immune response in vivo (Camberis et al., 2003; Neill et al., 2010) . During infection, the host mice mount both systemic and mucosal Th2 immune responses. IL-4-, IL-13-, and IL-5-producing GATA3 + Th cells (Th2) cells have been shown to be indispensable for clearance of the parasites. Th2 cells induce B cells to produce IgE via secretion of IL-4, IL-13, and CD40L. This B cell switch toward IgE production is a critical event in type 2 immune response. The host defense eventually causes parasite expulsion from the intestine within 2 weeks (Fallon et al., 2002) . We used this model to test Th2-mediated steroid production in vivo and analyzed pregnenolone expression during the height of worm burden at day 5 postinfection, and once clearance had occurred at day 10 postinfection. Th cells were purified from spleen and mesenteric lymph nodes (MLNs) at postinfection day 5 and day 10 and examined for Cyp11a1 protein expression by FACS ( Figure 2D ). On day 10 To test steroidogenic capacity, we cultured CD4 + T cells ex vivo for 24 hr and analyzed cell supernatant for pregnenolone by ELISA. Th cells from postinfected day 10 mice secreted significantly higher amounts of pregnenolone compared to uninfected control mice ( Figure 2F ).
Upregulation of Cyp11a1 Is Associated with a Suppressor Phenotype
Th2 cells are not a homogeneous population; they produce different cytokine combinations in different contexts, and the functional outcome depends on the cytokine expression profile of the cell or cell population (Abbas et al., 1996; Prussin et al., 2010; . Thus, it is likely that there is further heterogeneity within this cell population, so we profiled the association of Cyp11a1 expression with cytokine expression at the single-cell level by qPCR ( Figure 3A ). This allowed us to explore the coassociation of different Th2 factors with Cyp11a1. The coexpression analysis of Cyp11a1 mRNA with different Th2 cytokines showed a higher correlation with suppressor cytokines (IL-10 and TGF-b1) than effector cytokines (IL-4, IL-5, and IL-9) ( Figure 3B ). The strong correlation between Cyp11a1 and the Th2-master regulator transcription factor GATA3 confirmed the Th2 identity of these cells ( Figure 3B ). Upon hierarchical clustering on the matrix of pairwise Spearman correlation coefficients, Cyp11a1 clusters closely with TGF-b1, and IL-10, less closely with IL-13, IL-4, IL-5, and IL-9 ( Figure 3C ). This predicts a possible common or related regulatory mechanism governing Cyp11a1, and TGF-b1, and IL-10 expression, likely associated with suppression.
Single-Cell mRNA Sequencing Reveals the Gene Expression Identity of Steroidogenic Th2 Cells
To get further insight into the Cyp11a1 upregulation and a signature gene expression profile of Cyp11a1-producing cells, we sequenced mRNA of 91 single Th cells. Fifty-two cells were from the IL-13-GFP + fourth generation (G4P) and 39 were from the IL-13-GFP À second generation (G2N) (FACS gating shown in Figure 3A) . From the single-cell transcriptomes, we identified Cyp11a1-correlated genes as those with a Spearman's rank correlation coefficient >0.3. This included several known genes involved in the type 2 immune response, and revealed numerous uncharacterized factors ( Figure 4A ). The genes ranked top of the list according to Spearman's correlation coefficient and p value are shown in Figure 4A in the following categories: cytokine, surface receptor, transcription factors, and others. Complete lists can be found in the Supplemental Information (Tables S2, S3 , and S4). Many Cyp11a1-correlated factors such as Nfil3, Crem, Gata3, IL-24, IL-4, IL-5, Gzma, Ecm1, and Itgb3 have been previously reported to be Th2 specific (Horiuchi et al., 2011) . This indicates the Th2 origin of Cyp11a1-expressing cells. Expression of IL-4, GATA3, and Cyp11a1 mRNA at single-cell level is shown in Figure 4B .
Remarkably, the Cyp11a1-associated genes include many factors reported to be involved in immunosuppression, and development of regulatory or suppressor immune cells involved in restoration of immune homeostasis or immune tolerance. For example, Crem, Il10, TGFb1, Ctla2a, Ctla2b, Il2ra, Il2rb Il10ra, Ctla4, and Socs3 are well characterized for their role in immunosuppression. Nfil3 (Carey et al., 2013; Pletinckx et al., 2011) , Med13l (Angus and Nevins, 2012) , Foxo1 (Kerdiles et al., 2010; Ouyang et al., 2012) , IL-24 (Myles et al., 2013) , CD24 (Blair et al., 2010) , and Tnfrsf9 (Eckstrum and Bany, 2011) have also been reported as immunosuppressive factors but are less characterized. Numerous other Cyp11a1-correlated factors, including the highest-correlated, Vimentin (Vim), are implicated in steroid biosynthesis and sterol trafficking (Kraemer et al., 2013) (Shen et al., 2012) . Figure S3 shows the clustering heatmap of genes significantly positively or negatively correlated with Cyp11a1 based on their Spearman correlation matrix. The bottom-left cluster corresponds to genes positively correlated with Cyp11a1, and the top right is negatively correlated with Cyp11a1.
To gain further insight into the potential functional role of Cyp11a1-correlated genes in immune regulation, we selected 175 ''immune'' genes (Table S1 ). These genes are expressed at least at a basal level in the single-cell transcriptomic data set and are functionally characterized in immune responses. The hierarchical clustering heatmap with these selected genes revealed that Cyp11a1 clusters with many immunosuppressor genes. The Cyp11a1 cluster falls within a broader Th2-related gene cluster (Figures S4A and S4B) .
To find the Cyp11a1-expressing subpopulation of cells, we take genes highly positively or negatively correlated with Cyp11a1 (Spearman correlation > 0.35 or % 0.35). The heatmap based on the Spearman correlation coefficient matrix of these genes shows that most Cyp11a1-expressing cells cluster together as a single group ( Figure S4C ).
Ly6C1/Ly6C2-Expressing Th2 Cells Coexpress Cyp11a1 and Are Not Foxp3-Positive or Type 1 Regulatory T Cells For functional analysis of Cyp11a1-expressing cells, it was critical to identify an appropriate cell surface marker to purify these cells. From the single-cell RNA sequencing analysis, we found a number of cell-surface receptors correlated to Cyp11a1 expression, of which Ly6C2 is at the top based on Spearman rank correlation coefficient ( Figure 4A ). Ly6C1 appears as fourth on this list ( Figure 4A ). mRNA expression of these two homologs at single-cell level is plotted against Cyp11a1 mRNA expression and shown in Figure 4C . We purified Ly6C + Th2 cells using an antibody that binds both homologs.
The FACS profile of in-vitro-generated Th2 cells show that nearly all the Ly6C + cells coexpressed Cyp11a1 ( Figure S4D ). After flow-cytometric purification, we found Ly6C + cells are extremely homogeneous for Cyp11a1 expression when purified from a Th2 population. In contrast, Ly6C + cells purified from a Th1 population do not express Cyp11a1 ( Figure 4D ). The Ly6C + Th cells also coexpress GATA3, but not FoxP3, indicating a Th2-type rather than Treg-type cell population ( Figure 4D ). The single-cell RNA-seq analysis shows that these steroidogenic cells express IL-10 and TGF-b1 but not FoxP3, which raised a possibility that these cells are type 1 regulatory T cells (Tr1) (Gagliani et al., 2013) . To check this, we carried out FACS analysis of LAG3, CD49b, and TCR-b in the Ly6C + Th2 population. As expected, nearly all cells were found to be TCR-b positive but < 25% CD49b + and < 5% LAG3 + ( Figure S4E ); this means these cells are not Tr1 cells.
De Novo Steroid-Producing Th2 Cells Are Immunosuppessors A number of steroids have been shown to suppress immune responses through inhibition of effector immune cell proliferation, differentiation, and/or by inducing cell death (Rhen and Cidlowski, 2005; Sakiani et al., 2013; Taylor et al., 2005) . In Figures 3B and 4A, we show a correlation between Cyp11a1 expression and the suppressor cytokines IL-10 and TGF-b1. This led us to hypothesize that upon type 2 immune induction, activated Th2 cells produce pregnenolone as a signaling molecule to negatively regulate the immune effector response as a way to re-establish immune homeostasis. Two major effector events in type 2 immune response are (1) rapid Th cell proliferation after TCR activation to achieve sufficient numbers of Th2 cells and (2) B cell differentiation toward an IgE-secreting phenotype through class switch recombination. Pregnenolone Inhibits In Vitro Th1 and Th2 Cell Proliferation To test the effect of pregnenolone in Th cell proliferation, CD4 + naive Th cells were stained with CellTrace Violet and incubated in Th1 or Th2 activation-differentiation conditions in presence or absence of pregnenolone for 3 days. The presence of pregnenolone in the in vitro Th1 or Th2 culture conditions significantly retards cell proliferation when compared with vehicle-onlytreated conditions (Figures 5A and 5B ). Division indices, the average number of divisions that a cell (present in the starting population) has undergone, are presented in Figure 5C . Ly6C + Th2 Cells Suppress Th Cell Proliferation We observed that nearly all Ly6C + cells are Cyp11a1 + ( Figures   S4D and S4E ). We also observed that pregnenolone inhibits Th cell proliferation ( Figures 5A and 5B). These results raised the possibility that Ly6C + cells could suppress Th cell activation/ proliferation.
To check the functional physiological relevance of pregnenolone production by Ly6C + Cyp11a1 + Th2 cells, we used them in classical suppression assays (Collison and Vignali, 2011) . CellTrace-Violet-stained naive Th cells were used as responder cells. The responder cells proliferate with a mean division index (DI) of 2.17 ( Figure 5D , blue histogram in all panels) when plated on an anti-CD3e/CD28-coated plate. Proliferation is significantly suppressed when cocultured with Ly6C + Th2 cells in a 1:1 ratio (mean DI = 1.17) ( Figure 5D , red histogram in left upper panel). In contrast, addition of Ly6C À Th2 cells had little or insignificant effect on responder Th cell proliferation (mean DI = 2.1) (red histogram in upper middle panel). The suppressed proliferation rate was partly but significantly recovered when Ly6C + Th2 cells were pretreated with 250 mM aminoglutethimide (AG) or anti-IL-10 neutralizing antibody (20 mg/ml) for 24 hr and used in suppression assays in the presence of 250 mM AG or anti-IL-10 Ab (20 mg/ml) ( Figure 5D , red histogram in upper-right and lower-left panels, respectively). The proliferation was significantly recovered when Ly6C + Th2 cells were pretreated with the mixture of 250 mM AG and anti-IL-10 neutralizing antibody (20 mg/ml) for 24 hr and used in suppression assays in the presence of both AG (250 mM) and anti-IL-10 Ab (20 mg/ml) ( Figure 5D red histogram lower right panel). The additive effect of recovery, when IL-10 was neutralized in addition to blocking steroidogenesis, indicates the direct suppression by Cyp11a1 activity (i.e., steroid production). When a similar experiment was performed in parallel using Ly6C À Th2 cells, we observed no changes compared to Figure 3A) . Genes are listed according to their correlation coefficient value, higher to lower, top to bottom in each category. Genes previously reported to be involved in immunosuppression are red and genes not coexpressed are crossed out. RNA sequencing and analysis are as described in Figures S3 and S4 and Tables S2, S3, normal responder cell proliferation (blue histogram) ( Figure S5B ). The results do not exclude the possibility of involvement of both pregnenolone and IL-10 in the same pathway, as we observed a significant inhibition of IL-10 and TGF-b1 production when Th2 cells were polarized in presence of AG ( Figure 5E ). In contrast, AG treatment had no effect on interferon (IFN)-g production in Th1 cells, confirming the Th2 specificity ( Figure 5E ). Although we observed a correlation of TGF-b1 expression with Cyp11a1, neutralization of TGF-b1 had no effect on suppressor activity of Ly6C + cell, in contrast to IL-10 and pregnenolone ( Figure S5A ). Pregnenolone Negatively Regulates In Vitro B Cell Differentiation We studied the effect of pregnenolone on B cell class switch recombination using a well-established in vitro method (Uchimura et al., 2011) . In brief, purified splenic B cells were stained with CellTrace Violet and allowed to differentiate in the presence of lipopolysaccharide (LPS) and IL-4 with or without pregnenolone. On day 5 of stimulation, cell-surface IgG1 and IgE were analyzed by flow cytometry. We observed a dose-dependent reduction of IgG1 and IgE-producing cells upon pregnenolone treatment ( Figure 5F ). The inhibition of class switching was independent of cell proliferation at the doses of pregnenolone we administered ( Figure S5C ).
DISCUSSION
This investigation revealed the transcriptional upregulation of key enzymes of the steroidogenic pathway during Th cell differentiation. Single-cell RNA sequencing provided us with highresolution transcriptomic data, which revealed extensive heterogeneity within the Th2 population. We demonstrated the differential upregulation of Cyp11a1 in Th2 and showed that these cells are capable of de novo steroid synthesis, in vitro and in vivo.
Based on these observations, we propose the idea of a ''lymphosteroid,'' which can be defined as a steroid produced by a lymphocyte. We postulate that Th2 cells differentiate to steroid-producing Th2 cells in order to negatively regulate the type 2 immune response, possibly to restore homeostasis (Figure 6) . Pregnenolone-dependent inhibition of two major type 2 events, the Th cell proliferation and B cell immunoglobulin class switching, support this idea. Our discovery of de novo steroid production in Th2 cells introduces the possibility of a steroid regulatory intracrine, autocrine, and/or paracrine network within the immune system.
Steroid hormones regulate the immune system, partly by cellcycle inhibition, inhibiting effector immune cell differentiation and induction of cell death (Rhen and Cidlowski, 2005; Sakiani et al., 2013; Taylor et al., 2005) . Steroids may exert their action by genomic pathways, involving hormone binding to specific nuclear receptors (NRs) and subsequent modulation of gene transcription after binding to DNA. Alternatively, these hormones can transduce signal in nongenomic ways without any direct interaction with chromatin, as reviewed in Lö sel and Wehling (2003) . In the context of immune responses, both the genomic and nongenomic pathways of steroid hormone actions may be operating.
Steroid production as a result of immune induction from mucosal tissues, such as in the lung and intestine, has been shown to play a tolerogenic role to maintain tissue homeostasis (Cima et al., 2004; Hostettler et al., 2012) . It is interesting to note that intestinal mucosa and lung are target tissues of Th2-mediated immune response during helminthic infection and allergic asthma, respectively. Moreover, failure to induce lung steroid synthesis is asserted to be a cause of asthma and has been experimentally confirmed in the OVA-induced allergic airway inflammation model (Hostettler et al., 2012) . It is possible that Th2 cells play a role in restoring type 2 immune homeostasis by producing a lymphosteroid, which can act directly or could be used as a precursor substrate by other cells (lung epithelial and intestinal epithelial) to metabolize other downstream bioactive steroids. Hence, our study suggests it is worth further investigating the contribution of steroid-producing Th2 cells in these contexts.
Interestingly, two recent publications have shown that Cyp11a1 is involved in the regulation of cytotoxic T cells in allergic lung disease and development of peanut-induced intestinal anaphylaxis Wang et al., 2013) . This supports the physiological relevance of de novo steroid production by immune cells.
EXPERIMENTAL PROCEDURES Ethics Statement
All animal experiments were undertaken with the approval of the UK Home Office.
Th Cell Culture
Splenic naive Th cells were purified with the CD4 + CD62L + T Cell Isolation Kit II (Miltenyi Biotec) and polarized in vitro toward differentiated Th subtypes as described before in (Hebenstreit et al., 2011) . In brief, naive cells were seeded into anti-CD3e (1 mg/ml, clone 145-2C11, eBioscience) and anti-CD28 (5 mg/ml, clone 37.51, eBioscience) -coated plates. The medium contained the following cytokines and/or antibodies for the different Th subtypes: Th1, recombinant murine IL-12 (10 ng/ml, R&D Systems) and neutralizing anti-IL-4 (5 mg/ml, clone 11B11, eBioscience); Th2, recombinant murine IL-4 (10 ng/ml, R&D Systems) and neutralizing anti-IFN-g (5 mg/ml, clone XMG1.2, eBioscience); Th0, neutralizing anti-IL-4 (5 mg/ml, clone 11B11, eBioscience), neutralizing anti-IFN-g (5 mg/ml, clone XMG1.2, eBioscience). The cells were removed from the activation plate on day 4. Th1 and Th2 cells were cultured for another four days in the absence of CD3 and CD28 stimulation. When required, cells were restimulated with phorbol dibutyrate and ionomycin (500 ng/ml, Sigma-Aldrich) for 4 hr in the presence of Monensin (2 mM, eBioscience) for the last 2 hr.
RNA-Seq Data Generation, Mapping, and Expression-Level Quantification Poly(A)+ RNA was purified, reverse transcribed, and processed for sequencing as described previously (Hebenstreit et al., 2011 (Hebenstreit et al., , 2012 and in the Supplemental Experimental Procedures.
Single-Cell RNA Sequencing Single-cell RNA-seq was performed following the methods described before in Brennecke et al. (2013) and in the Supplemental Experimental Procedures.
Quantitative PCR Analysis
Quantitative PCR analysis was performed as previously described (Mahata et al., 2012) and can be found in the Supplemental Experimental Procedures.
Western Blot Antibodies
Anti-CYP11A1 (Santa Cruz Biotechnology, C-16) and anti-TBP (Abcam) were used.
Quantitative Single-Cell Gene Expression Analysis by qPCR Single-cell gene expression analysis was performed as described previously (Moignard et al., 2013) and can be found in the Supplemental Information.
Quantitative ELISA Th cells were seeded and/or maintained with equal density, and supernatants were analyzed following manufacturer's protocol (Pregnenolone ELISA kit, Abnova). Th cell culture media used were with charcoal stripped fetal bovine serum (FBS) (Life Technologies and Invitrogen). Absorbance was measured at 450 nm, and data were analyzed in GraphPad Prism 5.
Extraction of Steroids and Quantification
Two milliliters of cell media with the addition of internal standard was extracted via liquid/liquid extraction using 4 ml of MTBE. The mixture was vortexed and then frozen, after which the MTBE layer was removed and evaporated at 55 C under nitrogen. The dried extract was subsequently reconstituted in 100 ml of 50/50 methanol/water before LC-MS/MS analysis. The samples were analyzed on a Waters Xevo Mass Spectrometer with an electrospray ionization source operated in positive mode. The liquid chromatography system attached was a Waters Acquity uPLC with a HSS T3, 1.8 mm, 1.2 3 50 mm column. The gradient system consisting of water with 0.1% formic acid and methanol with 0.1% formic acid was used. Pregnenolone was quantified by comparison to a calibration series ranging from 0.5 to 100 ng/ml with respect to the internal standard pregnenolone-d 4. Nippostrongylus brasiliensis Infection C57BL/6 mice were inoculated subcutaneously with 300 third-stage larvae. On day 5 or 10 postinfection, spleens and mesenteric lymph nodes were harvested. CD4 + T cells were purified using MACS by depleting CD8a, CD11b, CD11c, Ly6G, and CD19-positive cells or selected positively with CD4 (L3T4) microbeads.
Ex Vivo Th Cell Culture for Pregnenolone ELISA CD4 + T cells (1 3 10 6 ) derived from N. brasiliensis infected or uninfected day 5 and day 10 mice were maintained in 200 ml charcoal stripped FBS containing Th cell-culture media for 24 hr without addition of any cytokines. Cell supernatants were analyzed for pregnenolone by ELISA (pregnenolone ELISA kit, Abnova).
FACS Analysis
In worm infection mouse model experiments, Th cells obtained on day 5 and day 10 postinfection from N. brasiliensis infected or control mice were analyzed by flow cytometry using anti-CD4-PE (eBioscience), anti-CYP11A1-fluorescein isothiocyanate (FITC) (mixture of Biorbyt and Santa Cruz), and anti-GATA3-Alexa Fluor 647 (eBioscience, Clone TWAJ) following the mouse regulatory T Cell staining kit protocol for FOXP3/transcription factors (eBioscience). Anti-CYP11A1 (Santa Cruz) antibody was conjugated to FITC using the Lynx rapid fluorescein antibody conjugation kit (AbD serotec) according to the manufacturer's instructions. Stained cells were analyzed on a FACSCalibur (BD Biosciences) flow cytometer using Cellquest Pro and FlowJo software. In vitro Th cell experiments: staining was performed following eBioscience intracellular staining protocol for cytokines and nuclear staining/transcription factor staining protocol for different transcription factors (GATA3, FOXP3) and Cyp11a1, using eBioscience reagents and kits. The following antibodies were fluorescent dye-conjugated primary antibodies: IL-4, IL-13, IL-10, IFN-g, TGF-b1, CD4, GATA3, FOXP3 (eBioscience); Ly6C, CD49b, LAG3, TCRb (BioLegend); Cyp11a1 (Bioss or mixture of Biorbyt and Santa Cruz). Stained cells were analyzed on a Fortessa (BD Biosciences) using FACSDiva and FlowJo software. CompBeads (BD Biosciences) were used for compensation where distinct positively stained populations were unavailable.
Th Cell Proliferation Assay
Naive Th cells were stained with CellTrace Violet following the CellTrace Violet Cell Proliferation Kit (Invitrogen) protocol and cultured under activation-differentiation conditions for Th1 or Th2 as described previously but in the presence or absence of pregnenolone for 3 days. Flow cytometry was performed using an LSRII (BD) and data analysis with FlowJo software.
Th Cell Suppression Assay Naive Th cells were stained with CellTrace Violet following the CellTrace Violet Cell Proliferation Kit (Invitrogen) protocol (responder cells) and cultured under activation conditions (plate coated with anti-CD3 and anti-CD28) in the presence or absence of FACS-sorted (Mo-Flo) Ly6C + or Ly6C À cells for 3 days. When required, Ly6C + cells were pretreated (24 hr) with anti-IL-10 (20 mg/ml), TGF-b1 neutralizing antibody (20 mg/ ml), and/or aminoglutethimide (250 mM), and the responder cell growth condition was supplemented with similar reagents (i.e., anti-IL-10 neutralizing antibody and/or aminoglutethimide). Flow cytometry was performed using a Fortessa (BD Biosciences) and analyzing data with FlowJo software.
Immunoglobulin Class Switch Recombination Splenic B cells from 8-to 12-week-old mice were purified by depletion of CD43 + cells using anti-CD43-coupled magnetic beads (Miltenyi Biotec), stained with CellTrace Violet following the CellTrace Violet Cell Proliferation Kit (Invitrogen) protocol, seeded in 96-well plates (1 3 10 5 per well) in 200 ml RPMI supplemented with 10% FBS, 0.05 mM 2-mercaptoethanol, 25 ng/ml recombinant mouse IL-4 (R&D Systems), and 40 mg/ml LPS (Sigma-Aldrich). On day 3 or day 5 of stimulation, B cell Fc receptors were blocked with PBS containing 2% rat serum and 10 mM EGTA and stained with FITC-conjugated anti-IgG1 (BD Biosciences) PE-conjugated IgE (BioLegend). Flow cytometry was performed using an LSRII (BD), excluding dead cells by 7-AAD staining. Data were analyzed with FlowJo software.
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